🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.88
-0.07 (-0.70%)
Nov 20, 2026, 4:00 PM EST - Market closed

Bioventus Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Bioventus stock has a consensus rating of "Strong Buy" and an average price target of $16.6. The average 1-year stock price forecast is 68.02% higher than the current stock price, while the lowest is $15 (+51.82%) and the highest is $18 (+82.19%).

Price Target: $16.6 (+68.02%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$15$16.6$16$18
Change+51.82%+68.02%+61.94%+82.19%

Analyst Ratings

The average analyst rating for Bioventus stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Oct '26Nov '26
Strong Buy333333
Buy222222
Hold000000
Sell000000
Strong Sell000000
Total555555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Cantor Fitzgerald
No rating
Cantor Fitzgerald
Buy
Reiterates
$15
BuyReiterates$15+51.82%Nov 13, 2026
Craig-Hallum
Craig-Hallum
Buy
Maintains
$18 → $16
BuyMaintains$18 → $16+61.94%Nov 3, 2026
Barrington
Barrington
Buy
Maintains
$18 → $16
BuyMaintains$18 → $16+61.94%Nov 3, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$19 → $18
BuyReiterates$19 → $18+82.19%Nov 3, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
594.93M
from 568.09M
Increased by 4.72%
Revenue Next Year
633.08M
from 594.93M
Increased by 6.41%
EPS This Year
0.77
from 0.68
Increased by 12.94%
EPS Next Year
0.89
from 0.77
Increased by 15.63%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
430.90M512.12M512.35M573.28M568.09M594.93M
Revenue Growth
34.17%18.85%0.05%11.89%-0.91%4.72%
Gross Profit
302.71M331.08M328.19M388.23M388.16M416.69M
Gross Margin
70.25%64.65%64.06%67.72%68.33%70.04%
Operating Income
21.05M-34.66M2.03M36.63M56.34M103.44M
Net Income
19.38M-158.70M-156.23M-36.13M22.73M55.74M
EPS
----0.680.77
EPS Growth
----38.78%12.94%
Forward PE
21.5017.1721.8220.009.7912.86
Free Cash Flow
----72.11M76.72M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High606.0M
Avg594.9M
Low591.1M

Revenue Growth

Revenue Growth202620272028
High
6.7%
Avg
4.7%
Low
4.1%

EPS Forecast

EPS202620272028
High0.78
Avg0.77
Low0.75

EPS Growth

EPS Growth202620272028
High
14.7%
Avg
12.9%
Low
10.3%